|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||51.00 - 60.00|
|52-week range||39.10 - 167.00|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||N/A|
|Earnings date||07 Aug 2019|
|Forward dividend & yield||N/A (N/A)|
|1y target est||70.00|
Even if it's not a huge purchase, we think it was good to see that Timothy Watts, the CEO & Director of Shield...
Shield Therapeutics plc (LON:STX) shareholders will have a reason to smile today, with the analysts making substantial...
With the business potentially at an important milestone, we thought we'd take a closer look at Shield Therapeutics...